Chemotherapy induced hair-loss can be very demotivating, distressing and it knocks the confidence of many who have to go through it.
What is Translational Cancer Research?
Cancer research is one of the most talked about topics and rightly so. Cancer research is making incredible breakthroughs and paving the way for a future where cancer can be cured and prevented.
Funding Awarded By Sydney Vital
The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.
# | Awardee | Institution | Supervisor | Research Title | Amount Awarded |
---|---|---|---|---|---|
1 | Jerikho Bulanadi | Kolling Institute of Medical Research | Prof Ross Smith | Chemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery. | $15,000 |
2 | Emma Colvill | Sydney University Medical School | Prof Paul Keall | The bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer | $15,000 |
3 | Grace Gifford | Haematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, Sydney | Dr William Stevenson | Gene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making. | $15,000 |
4 | Dr Anthony Glover | Kolling Institute of Medical Research, Royal North Shore Hospital | Prof Stanley Sidhu | Noncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes. | $15,000 |
5 | Diana Hatoum | Faculty of Science, UTS Sydney | Dr Najah Nassif | A Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer. | $15,000 |
6 | Samuel Brennan | Faculty of Science, UTS Sydney | Dr Rose Martiniello-Wilks | Development of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis. | $15,000 |
7 | Ben Harris | Sydney Medical School, University of Sydney | Dr Kellie Charles | Investigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation. | $15,000 |
8 | Adrian Lee | Bill Walsh Translation Cancer Research Laboratory, Kolling Institute | Dr Viive Howell | "Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with glioblastoma multiforme?" | $15,000 |
9 | Jaynish Shah | Sydney Medical School, University of Sydney | Prof Deborah Marsh | Investigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key? | $15,000 |